Summary of the Second Employee Stock Ownership Plan (Draft)
Securities Abbreviation: Pro Pharmaceutical
Securities Code: 000739
Announcement Number: 2026-10
Date: March 2026
Declaration
The company and all members of the board guarantee that the content of this employee stock ownership plan is true, accurate, complete, and does not contain false records, misleading statements, or significant omissions.
Risk Warning
- This employee stock ownership plan must be approved by the company's shareholders' meeting before implementation, and there is uncertainty regarding whether such approval will be obtained.
- The funding sources, contribution ratios, and implementation plans related to this employee stock ownership plan are preliminary proposals, and there is uncertainty regarding the completion of the plan.
- Employees will participate in this employee stock ownership plan voluntarily and at their own risk. If the subscription amount is low, there is a risk that the plan may not reach the expected scale.
- The company will disclose relevant progress according to regulations, and investors are advised to make cautious decisions and pay attention to investment risks.
Special Reminder
The terms used in this section are consistent with those in the "Definitions" section.